Replies to post #790446 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

You are the one in need of it.None of your pumps over the time have been anywhere close to true . They usually are either wide speculations or some fringe conspiracy theories . 

[dstock07734]

ILT,

Take a look at those terminated trials by BNTX. There are five trials that the results were uploaded. The figures are about the data on mortality. Can you believe the UK government is enthusiastic about this mRNA cancer vaccine? Had $NWBO had even one trial like this, the vultures would try to devour us alive. But no media talk about those terminated trials.

BTW, my prediction is that once the big news is announced, Merck is going to throw away immediately the collaboration deal with Moderna like a piece of trash.

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy
https://clinicaltrials.gov/study/NCT05435339


Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors
https://clinicaltrials.gov/study/NCT04683939


BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
https://clinicaltrials.gov/study/NCT04455620


PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (PRO-MERIT)
https://clinicaltrials.gov/study/NCT04382898



Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
https://clinicaltrials.gov/study/NCT04101357


Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma
https://clinicaltrials.gov/study/NCT06069778

A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma
https://clinicaltrials.gov/study/NCT04625205

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
https://clinicaltrials.gov/study/NCT03871348

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
https://clinicaltrials.gov/study/NCT03597282

Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies
https://clinicaltrials.gov/study/NCT02672917